[PDF][PDF] 胰胆管造影术后发生胰腺炎的危险因素分析
李燕， 田铸， 徐梦林， 翟军… - Progress in Modern …, 2019 - biomed.cnjournals.com
… Outcome of patients with cardiac amyloidosis admitted to an intensive care unit for acute heart
… Colchicine-sensitive nephrotic syndrome due to AA amyloidosis[J]. Amyloid, 2011, 18(3): …
… Colchicine-sensitive nephrotic syndrome due to AA amyloidosis[J]. Amyloid, 2011, 18(3): …
[PDF][PDF] 展望泛血管疾病防控——从疾病治疗到综合管理
杨靖， 张英梅， 葛均波 - 中华心血管病杂志(网络版), 2021 - cvjc.org.cn
… between adiposity and cardiovascular outcomes: an umbrella review and meta-analysis
of … Colchicine in patients with chronic coronary disease[J]. N Engl J Med, 2020,383(19):1838-…
of … Colchicine in patients with chronic coronary disease[J]. N Engl J Med, 2020,383(19):1838-…
Febuxostat 和Allopurinol 之心血管安全性比較: 以傾向分數配對之世代研究
蘇靖晏 - 2018 - tdr.lib.ntu.edu.tw
… and CV events. Also, the dose-response effects of febuxostat on the CV outcomes were …
診斷及colchicine 處方, 當中有2.2%的人符合此定義;三,至少有兩次以上就診紀錄同時有痛風診斷及 …
診斷及colchicine 處方, 當中有2.2%的人符合此定義;三,至少有兩次以上就診紀錄同時有痛風診斷及 …
动脉粥样硬化性心血管疾病的药物治疗研究进展
梁思佳， 周家国 - 药学进展, 2023 - pps.cpu.edu.cn
… This review describes the research progress of these drugs and related targets, in the
hope of exploring new direction of clinical drug treatment for ASCVD in the future. …
hope of exploring new direction of clinical drug treatment for ASCVD in the future. …
姜黄素抗肝窦毛细血管化作用及机制
段雪琳， 彭岳， 赵铁建， 韦燕飞， 黎桂玉 - 中国组织工程研究, 2018 - cjter.com
… Moreover, all above mRNA and protein expression levels in the high-dose curcumin group
were significantly lower than those in the colchicine and salvia miltiorrhiza phenolic acid B …
were significantly lower than those in the colchicine and salvia miltiorrhiza phenolic acid B …
[PDF][PDF] 表现为腹部淀粉样瘤及多系统功能异常的AA 型系统性淀粉样变性1 例暨文献复习
卢蓉， 许辉， 唐文彬， 李晓照 - Progress in Modern …, 2019 - biomed.cnjournals.com
… Outcome of patients with cardiac amyloidosis admitted to an intensive care unit for acute heart
… Colchicine-sensitive nephrotic syndrome due to AA amyloidosis[J]. Amyloid, 2011, 18(3): …
… Colchicine-sensitive nephrotic syndrome due to AA amyloidosis[J]. Amyloid, 2011, 18(3): …
创伤性脑损伤后的肝损害: 前景和潜在治疗靶点
S Villapol - 中国神经再生研究(英文版), 2016 - sjzsyj.com.cn
: 创伤性脑损伤是一种严重的病理情况, 是持续性的公共卫生和医疗问题. 虽然创伤性脑损伤是有
因为脑组织直接损失而造成长期后果, 但治疗主要集中在减轻继发性损害方面. 然而, 尽管创伤性…
因为脑组织直接损失而造成长期后果, 但治疗主要集中在减轻继发性损害方面. 然而, 尽管创伤性…
共培养条件下人脐血间充质干细胞抑制心肌细胞凋亡: 是否安全有效?
杨水祥， 黄景玲 - 中国组织工程研究, 2010 - cjter.com
… (5×106) were cultured with DMEM/F12 and 0.3 μg/mL colchicine for 4 hours. Metaphase
chromosome spreads were prepared. Then, standard G-banding with trypsin-Giemsa staining …
chromosome spreads were prepared. Then, standard G-banding with trypsin-Giemsa staining …
[HTML][HTML] 残余炎症风险与急性心肌梗死的研究进展
热依扎， 达吾林 - Advances in Clinical Medicine, 2024 - hanspub.org
… is considered an important indicator for as-sessing the risk of atherosclerotic cardiovascular
… of the common adverse cardiovascular events of atherosclerotic cardiovascular disease. …
… of the common adverse cardiovascular events of atherosclerotic cardiovascular disease. …
[PDF][PDF] 非布司他与别嘌醇心血管安全性比较的meta 分析
邓健浩， 张家兴， 庄茜 - 药物不良反应杂志, 2022 - cadrj.com
… Critical evaluation of the Newcastle‑Ottawa scale for the assessment of the quality of …
Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention …
Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention …